Previous Next

Quality of life – a matter of your heart

Quality of life of patients with serious heart disease and severe damage of the pulmonary valve is a concerning matter to us. 

We are a biotechnology company focused on development and production of biological implants. Primarily for the replacement of affected pulmonary valves. All our implants are produced with our proprietary decellularization technique. Implants treated this way can grow naturally and become part of the patients body. These implants furthermore minimize the use of longterm medication, with their negative side-effects, and growth related reoperations.

This results in a significant improvement of the quality of life, especially for the younger patients.

If you are interested there is more to learn about us, our CE approved products Matrix P plus N and Matrix Patch, the medical indications and our decellularization technique

TÜV Zertifikat

TÜV Rheinland LGA Products GmbH certifies the admission for Matrix P plus N™, Matrix P™ as well as Matrix Patches in all sizes. Furthermore autotissue is licensed as manufacturer in accordance with EN ISO 9001:2008 as weil as EN ISO 13485:2003 + AC:2009.